SABBY MANAGEMENT, LLC - CATABASIS PHARMACEUTICALS IN ownership

CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P906. A total of 3 filers reported holding CATABASIS PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$171,000
+163.1%
277
+174.3%
0.03%
+100.0%
Q2 2020$65,0001010.01%
Other shareholders

There were no reported owners of CATABASIS PHARMACEUTICALS IN in Q4 2020.

NameSharesValueWeighting ↓
View complete list of CATABASIS PHARMACEUTICALS IN shareholders